Hong, S.-h.; Kang, N.; Kim, O.; Hong, S.A.; Park, J.; Kim, J.; Lee, M.-A.; Kang, J.
EGFR-Tyrosine Kinase Inhibitors Induced Activation of the Autocrine CXCL10/CXCR3 Pathway through Crosstalk between the Tumor and the Microenvironment in EGFR-Mutant Lung Cancer. Cancers 2023, 15, 124.
https://doi.org/10.3390/cancers15010124
AMA Style
Hong S-h, Kang N, Kim O, Hong SA, Park J, Kim J, Lee M-A, Kang J.
EGFR-Tyrosine Kinase Inhibitors Induced Activation of the Autocrine CXCL10/CXCR3 Pathway through Crosstalk between the Tumor and the Microenvironment in EGFR-Mutant Lung Cancer. Cancers. 2023; 15(1):124.
https://doi.org/10.3390/cancers15010124
Chicago/Turabian Style
Hong, Sook-hee, Nahyeon Kang, Okran Kim, Soon Auck Hong, Juyeon Park, Joori Kim, Myung-Ah Lee, and Jinhyoung Kang.
2023. "EGFR-Tyrosine Kinase Inhibitors Induced Activation of the Autocrine CXCL10/CXCR3 Pathway through Crosstalk between the Tumor and the Microenvironment in EGFR-Mutant Lung Cancer" Cancers 15, no. 1: 124.
https://doi.org/10.3390/cancers15010124
APA Style
Hong, S.-h., Kang, N., Kim, O., Hong, S. A., Park, J., Kim, J., Lee, M.-A., & Kang, J.
(2023). EGFR-Tyrosine Kinase Inhibitors Induced Activation of the Autocrine CXCL10/CXCR3 Pathway through Crosstalk between the Tumor and the Microenvironment in EGFR-Mutant Lung Cancer. Cancers, 15(1), 124.
https://doi.org/10.3390/cancers15010124